LBO

The model stays consistent — both sides always balance. The sponsor immediately sees the minimum equity check and can test whether the deal meets its return hurdles (typically 20–25% IRR over 5 years).

In modeling tests you are often asked 'If the sponsor wants to put in less equity, what changes?' — the clean answer: only if more debt is available (a higher leverage multiple or an extra tranche), otherwise nothing. Equity is the output, not the input.

Total Uses $354m — this amount must be covered by Sources. With 5x debt ($200m) and $15m of existing cash, the equity check works out to ~$140m (40% equity share) — typical for middle-market LBOs.

Equity check for the sponsor: $139m (39% of Total Uses). Debt/EBITDA ratio 5.0x — at the top of the middle-market range, but still financeable with stable cash flow.

Sanity check: both sides = $354m ✓.

Question: "What happens at 6x debt?"
Answer: "The equity check falls to $99m (28%), but lenders then usually demand a mezzanine tranche or decline — cash-flow coverage gets too tight"

Transaction fees go through once via investing or operating in Year 1, depending on the capitalization decision. Financing fees do not show as a separate line but as a higher effective interest rate over the entire debt life.

Question: "Where do you see the difference in the cash flow statement?"
Answer: "Transaction fees go through once — Year 1 investing or operating, depending on the capitalization decision. Financing fees don't show as a separate line but as a higher effective interest rate over the whole debt life under the effective-interest method (IFRS 9)"

$30m cash on the balance sheet. Of that, $8m trapped (China subsidiary), $10m operating need. Available as a source: 30 − 8 − 10 = $12m.

Aggressive cash use effectively increases leverage — if working capital has to be topped up after closing, it is funded from operating cash flow, which delays debt paydown.

Seniors often test 'What happens if the sponsor takes $30m but the target can only spare $12m?' — answer: the first working-capital peak can't be covered, so the sponsor has to inject more equity or draw the RCF. Therefore: assume conservative cash availability.

There are two modeling conventions:

1. Net mode (common in Europe): Sources shows $198m net proceeds; OID does not appear separately
2. Gross mode (common in US modeling): Sources shows $200m face; OID $2m as an additional Use ('financing fees')

Both arrive at the same equity check, but the table looks different.

OID amortizes over the debt's life for accounting — under IFRS 9 (amortised cost, effective-interest method, §5.4) and likewise under US GAAP (ASC 835-30, where OID and debt issuance costs are shown as a direct deduction from the debt's carrying amount). It raises the effective yield above the stated coupon: on a 7-year TLB with a 5% coupon issued at 98 (2% OID), the yield-to-maturity is ~5.35%. In modeling, OID amortization is modeled as an additional (non-cash) interest expense.

Tax shield at the sponsor level — interest on the shareholder loan reduces the HoldCo's taxable profit. On $100m of sponsor equity split into $10m common + $90m shareholder loan at 8% PIK, ~$7.2m of annual interest expense arises at the HoldCo level — reducing taxable operating profit at the HoldCo/group level (exit gains on the shares are in any case largely tax-exempt under a participation exemption in many jurisdictions, often ~95%).

This is standard, but the interest deductibility limit caps the deduction at ~30% of EBITDA in many jurisdictions — seniors often ask when that becomes relevant. Answer: when the sponsor-loan volume is very large relative to EBITDA, or when operating-level interest already exhausts the limit.

• Common equity multiple at exit: the main share. $100m of common equity at 2.5x becomes $250m.
• PIK loan accretion: secondary, but tax-free for the sponsor. $50m at 10% PIK compounds to ~$80.5m over 5 years.

The standard is a 4-year vesting with a 1-year cliff. Good-leaver clauses (retirement, death, disability) grant full vesting plus a fair-market buyout. Bad-leaver clauses (termination for cause, non-compete breach) trigger forfeiture of the unvested portion and usually a cost-basis repayment on the vested portion.

Question: "What happens to management equity if someone has to leave before exit?"
Answer: "The vesting schedule and good-leaver / bad-leaver clauses in the SHA (shareholders' agreement) govern this. The standard is 4 years' vesting with a 1-year cliff. A good leaver receives full fair-market value for vested shares; a bad leaver forfeits unvested shares and gets only cost basis back on the vested ones"

The founding family of Industrial Manufacturing Co receives a $285m equity purchase price on the sale. They roll $30m (10.5%) into the NewCo:

The sponsor's equity need falls by the rollover amount — with Total Uses $354m, $200m debt, $15m cash: Sponsor Equity = 354 − 200 − 15 − 30 = $109m (instead of $139m without rollover).

Rollover equity is very common in middle-market family-owned buyouts (60–70% of them) and signals to the market 'the seller believes in the future'. From the sponsor's view: a strong alliance with the operating family, but more complex governance setups (family veto, drag-along rights).

The founding family sells Industrial Manufacturing Co for $285m of equity. Structuring:

A vendor loan is typically:

• Subordinated to bank financing
• Interest-bearing (5–8% PIK common)
• 3–7 year term, repaid at the end ('bullet')

From the seller's view: a higher total sale price (through interest), possible tax deferral. From the buyer's view: less sponsor equity needed, but additional interest burden.

Common pitfall — many junior analysts forget that the vendor loan sits between Senior Debt and Sponsor Equity in the capital structure. It counts toward the interest deductibility limit calculation. In insolvency it behaves like mezzanine.

Question: "What extra costs does a P2P have versus a carve-out?"
Answer: "Securities-regulator and tender costs, squeeze-out legal and expert fees, and the appraisal-proceedings risk if tender acceptance stays below the squeeze-out threshold. In total, a P2P's Total Uses run 5–10% higher than a comparable carve-out"

• Forgetting to refinance existing debt: change-of-control clause not checked
• Trapped cash assumed 100% available (cash in a foreign subsidiary that can't be repatriated without withholding-tax friction)
• Financing fees set at only 1% (typically 2.5–3% of debt volume)
• Equity share below 25%: the bank indication is missing or too aggressive
• Senior leverage above 5.5x in a cyclical sector: covenant stress built in

In a senior review, mention the sanity checks proactively ("Total Sources equals Total Uses, leverage is 5.2x at the top of the range but financeable, fees at 4.8% within the bracket") — this signals ownership rather than 'here's the table, please check it'.

Pro-forma EBITDA is usually 10–20% above reported EBITDA in the middle market. Bankers and lenders build their own bridge — the sponsor bridge is rarely taken 1:1.

Question: "Which add-back would be critical?"
Answer: "Synergies, because they are forward-looking and the sponsor carries the burden of proof. I'd have 50% verified in a quality-of-earnings report"

The 56% EBITDA growth breaks down into ~28pp from sales volume and ~28pp from margin expansion (mix effect ~0). That is a 9.4% CAGR — at the top end for middle-market machinery, plausible only with a clear operational-excellence plan.

At 9%+ EBITDA CAGR, immediately ask 'Where does the margin expansion come from?' — typical sources: procurement synergies (−2–3% COGS), headcount cost reduction (−1–2% SG&A), pricing power (+0.5–1% sales). Anyone who writes a 22% margin into the forecast without justification hasn't thought the pitch book through.

MidCap Machinery Inc historically at a 6% capex ratio. Sponsor plan: 4% in Years 1–2, then back to 6%.

A capex holiday in Years 1–2 frees up $8m of additional cash for debt paydown — relevant for leverage reduction and IRR.

Seniors test 'What does the DD report say about the capex hypothesis?' — a good answer points to the asset-age profile in the commercial DD.

In the middle market, often a $20m+ cash quick win from professional working-capital management — typically a 'Day-1 initiative' for PE sponsors.

Seniors ask 'What would your 100-day plan for OWC be?' — a structured answer: Days 1–30 DSO/DIO/DPO baseline, Days 30–60 quick wins (DSO), Days 60–100 structural levers (DIO via SKU reduction, DPO via supplier negotiation).

• Interest deduction on new acquisition debt: capped in most developed markets at ~30% of a tax-EBITDA measure — the EU's ATAD rule (30% of EBITDA, with a de-minimis of up to €3m) and the US IRC §163(j) limit (30% of adjusted taxable income).
• Holding structures — a participation exemption makes dividends and share-sale gains tax-free or largely tax-free at a corporate holding: 100% exempt in e.g. the UK (substantial shareholdings exemption), the Netherlands and Luxembourg; 95% exempt in e.g. Germany (~1.5% effective tax). The US has no capital-gains participation exemption, only a dividends-received deduction.
• Loss carryforwards from the acquisition: but most jurisdictions restrict their use after a change in ownership (e.g. US IRC §382 after a >50-percentage-point ownership change; similar change-of-ownership rules in the UK and Germany).

Question: "What effective rate do you use in the model?"
Answer: "In an LBO usually 25–28% effective, because interest deductions and holding structures pull the rate down. Without those I'd land around the blended statutory rate — 25–30% depending on the country." Quoting a flat 30% without mentioning the tax optimization lacks modeling depth

1. You have to model the limit annually — with growing EBITDA the carryforward can be used later
2. The tax shield is lower than a naive calculation suggests
3. With aggressive leverage the limit almost always bites in Years 1–2

In LBOs the interest-limit calculation belongs in every model. Seniors often test 'What happens to the carryforward at exit?' — answer: it stays with the target company, but can be restricted or forfeited on a change of ownership (e.g. US IRC §382 also covers disallowed §163(j) carryforwards; Germany's §8c rule is a similar example).

• Management case: 25–30% IRR (the sponsor shows this to LPs)
• Bank case: 15–20% IRR, MOIC 1.5–2.0x (the sponsor uses this to assess downside risk)

Both cases run in parallel through the same scenario switch. The sponsor decides the equity investment based on bank-case IRR and covenant headroom — the management case serves to defend the story to LPs.

Question: "Which case determines the equity check?"
Answer: "The bank case, because it drives the lenders' decision. The sponsor optimizes IRR in the management case but only commits once the bank case also holds up — DSCR above 1.5x, covenant headroom intact, MOIC above 1.5x"

The convention is tricky and junior modelers often stumble here:

• ΔWC = increase (positive number): more cash is tied up in operating working capital → cash out, subtract as usual.
• ΔWC = decrease (negative number): WC declines, cash is freed up → cash inflow, and subtracting it turns into a plus.

In the case above, ΔWC = −$5m means WC fell by $5m, so $5m flowed back into cash. In the formula: − (−$5) = + $5.

D&A. It is non-cash, so it is irrelevant to the cash calculation. On the path via NOPAT you would first subtract D&A (for the tax base), then add it back — net effect zero.

Question: "Why does ΔWC show up in the model sometimes with a plus, sometimes with a minus?"
Answer: "A ΔWC increase is a cash out (more WC ties up cash), a ΔWC decrease is a cash inflow (WC release frees up cash). In the calculation ΔWC is always subtracted — a negative ΔWC becomes, through the minus, a positive effect on CFADR. The clean path is: EBITDA − cash taxes − Capex − ΔWC − amortization"

MidCap Pharma Inc, revenue $300m, minimum cash 2% = $6m.

The model sets minimum cash as a floor — the Cash Sweep only takes cash above that level. If the modeler forgets the floor, liquidity is understated and amortization overstated.

Seniors test 'How high is your min-cash floor?' — the answer should be justified by sector, not set as a blanket figure. Pharma 1.5%, construction 3%, IT services 0.8% are typical values.

EBITDA multiples on companies that capitalize R&D are not directly comparable. Standard bridge: 'EBITDA before capitalized R&D' — some middle-market tech companies report both.

Question: "How would you value software EBITDA?"
Answer: "I would use EBITDA ex-capitalized R&D, because that shows the honest cash-flow generation. Most lenders do the same"

• The net debt definition often counts the pension DBO as a "debt-like item" → it raises effective leverage
• Cash contributions to the pension reduce CFADR every year (typically 2-5% of EBITDA)
• If the plan is underfunded, the sponsor may face additional cash needs in Years 1-2

'How large is the DBO as a % of EBITDA?' is a senior question in industrials. In the middle market, >2x EBITDA is treated as a red flag — banks cut leverage.

The short form is enough for 80% of pricing discussions. You need the full model for interest-deductibility-limit detail, tax NOL tracking, or structurally complex carve-outs.

Question: "When do you need the full model?"
Answer: "When the tax rate has to be variable (interest deductibility limit, NOL), for carve-outs with pro-forma adjustments, or when the lender requires a 3-statement model"

A middle-market company with $50m of real-estate lease commitments over 10 years, 5% discount rate.

1. EBITDA inflation: IFRS 16 EBITDA is 5-15% higher than historical comparatives
2. Net debt definition: the lease liability is often counted as "debt-like" → the true leverage ratio
3. Banks: many lenders exclude IFRS 16 effects in covenants ("frozen GAAP")

Question: "How do you treat IFRS 16 in your model?"
Answer: "Clarify explicitly whether EBITDA is pre- or post-IFRS-16; net debt including the lease liability; multiples used consistently"

Run-rate is usually 5-15% higher than LTM, because sellers typically present it during growth periods. In the middle market it is often presented as 'pro-forma EBITDA'.

In a pricing negotiation many sellers say 'But run-rate is 15% higher than LTM.' — the clean buyer response: 'We take LTM as the pricing basis; we accept run-rate only if QoE confirms the sustainability of the one-off items.' A classic negotiation position.

• Excess Cash: $30m
• Outstanding TLB: $80m
• Sweep %: 75%
• Sweep = MIN(30, 80, 22.5) = $22.5m

Three bounds at once:

1. You can't sweep more than the available excess cash
2. You can't sweep more than the outstanding debt
3. You can't sweep more than the contractual sweep percentage allows

In a modeling test bankers say 'Build me the cash sweep waterfall' — a structured answer: 'Excess cash → senior debt first in full, then mezzanine, then shareholder loan. Each tranche gets its own MIN bound.' Cleanly built with helper cells, not one mega-formula.

The order matters — first cover operating cash, then cash interest, then the mandatory repayment, then the min-cash floor (typically 8–12 weeks of operating coverage), and only what sits above that flows into the cash sweep.

Without the sweep the Year-End TLB would be $195m instead of $164m. At a 9x EBITDA exit multiple that shifts equity value by roughly $30m — worth a low-single-digit number of percentage points on the IRR.

Question: "What would more cash sweep do to the IRR?"
Answer: "On a typical 5-year hold at a 9x exit multiple, $30m of extra repayment delivers roughly 2–3 percentage points more IRR. Trade-off: cash tied up in the sweep can't be used for bolt-ons — which is why 100% sweep is rarely optimal"

The sponsor has an incentive to cut leverage fast — once below the threshold, excess cash can go to dividends, add-ons, or recap reserves instead of repayment.

Question: "Why does the lender offer the step-down?"
Answer: "The lender wants cash capture while leverage is high and accepts room for the sponsor once de-levered — that's standard middle-market practice"

Senior lenders have the first claim — they contractually require excess cash to flow to them first, because:

1. Lowest coupon (typically SOFR + 350-450bps): the least margin
2. Highest security (first lien): earns the smallest risk premium
3. Shortest maturity: meant to be repaid quickly

Question: "Would you ever repay mezz before senior?"
Answer: "Only once senior is already repaid. Mezz has high coupons, but the make-whole on early repayment makes it economically unattractive"

A clean BASE structure:

1. Makes modeling errors visible (when the balance sheet doesn't balance)
2. Enables clear senior-coaching conversations ('Begin minus Subtractions plus Additions equals Ending')
3. Audit-ready for lenders and the investment committee

In a modeling test you're often told 'Walk me through your debt schedule' — a clean senior-level answer: 'I use a BASE structure: Beginning, Additions, Subtractions Mandatory, Subtractions Sweep, Ending. That way the senior sees immediately whether the model holds together.'

• Year-End: on excess cash → repay the RCF first (no make-whole, low cost)
• Year-Begin next year: if cash is below the min-cash floor → draw the RCF again
• Net effect: the RCF balances seasonality automatically

Question: "When do you draw the RCF in the forecast?"
Answer: "Seasonal working-capital peaks (typically Q1-Q2 in the middle market), or for one-off cash needs like bolt-on acquisitions below the sweep threshold"

The sponsor negotiates the holiday in the term sheet — the lender often accepts if:

1. There is a clearly defined use of cash (plan submitted)
2. The holiday is time-limited (12-24 months standard)
3. The sweep runs at full rate again after the holiday

Question: "Would you negotiate a sweep holiday?"
Answer: "Yes, a 12-month holiday to build working capital in a carve-out case. The sweep starts at full rate from Year 2. It costs ~150bps of IRR but gives operational stability during the integration phase"

1. Excess cash on the balance sheet reduces net debt → raises equity value at exit
2. But: cash earns no return (or only a low money-market yield)
3. More efficient would be: a recap dividend or a bolt-on — cash back to the sponsor or put to productive use

Question: "What do you do with the accumulated cash?"
Answer: "A recap dividend after Year 5 — the sponsor pulls out excess cash via a dividend and keeps equity-value optionality on the remaining business. Senior bankers expect this answer"

The sponsor invested $150m of equity in Year 0. After 3 years: debt reduced from 200 → $100m, EBITDA grown from 40 → $55m.

The sponsor has 50% of its equity back — IRR rises sharply, because:

1. An earlier cash distribution = higher time value
2. Reduced equity-at-risk = a higher multiple at exit

Question: "When is a recap rational?"
Answer: "When leverage has fallen below 2.5x EBITDA AND the market for new debt is favorable AND the exit is still 2-3 years out. Classically Year 3-4 in a 5-7 year hold"

Cash needs are low up front (sponsor-friendly), but the bullet in the final year needs refinancing or an exit. Refinancing risk = market conditions in Year 7.

Question: "Which repayment structure would you negotiate?"
Answer: "Step-up with a bullet on the TLB, because the sponsor has more cash for IRR-relevant investments early on. The sweep covers the refi risk"

Contractual ECF is usually 20-40% lower than modeling CFADR — which gives the sponsor more room without triggering the sweep.

Question: "Which items do you negotiate in the ECF definition?"
Answer: "The permitted-acquisitions threshold, the permitted-investments cap, the tax-distribution floor. Typically 5-10% of EBITDA per category. These carve-outs are the sponsor-friendly items"

• The senior lender has the strongest interest in cash capture and therefore requires the sweep in the credit agreement.
• Second lien is often only swept after a complete senior pay-down.
• Mezzanine accretes over the hold period and is typically repaid only at exit: either from sale proceeds or through refinancing by the new sponsor.
• Holdco PIK notes are structurally removed from OpCo cash flow: the sweep at the OpCo level cannot reach them.

Question: "Why doesn't the sponsor repay the mezzanine voluntarily?"
Answer: "The soft-call premium makes it uneconomic. The 12–15% mezz coupon looks expensive, but the PIK tax shield partly offsets it. The sponsor waits for the exit or a refi opportunity at par"

100% sweep maximizes repayment but locks up cash for bolt-ons. 0% keeps cash, but lenders rarely accept it. 50–75% balances both effects.

At a low entry multiple (buy-and-build with an aggressive add-on plan) lean to 50% sweep, because bolt-ons deliver more IRR than extra repayment. For stable cash-flow targets without an M&A pipeline lean to 75% sweep — excess cash has no productive use.

Question: "How high should the sweep be?"
Answer: "50–75% with a step-down to 25–50% once senior leverage falls below 3.0x. Higher than 75% and you lose optionality for bolt-ons. Lower than 50% and no lender accepts it"

The unitranche share in the middle market has risen to ~40-50% of all LBO financings (2018: 20%). Drivers: speed, flexibility, single-counterparty convenience.

Question: "When do you use a unitranche?"
Answer: "For smaller middle-market deals ($50-150m EBITDA) where speed matters and the sponsor has a clear story. For larger deals or first-time sponsors, prefer the classic sandwich for market breadth"

The $70m of mezzanine grows through the annual 5% PIK to ~$89m after 5 years. At exit the sponsor therefore repays not $70m of mezz but $89m. Compounding effect: not 5% × 5 = 25%, but (1.05)^5 − 1 = 27.6%.

• Year 1 cash out: $27.3m (senior + mezz cash)
• Year 1 non-cash: $3.5m PIK (accrued onto the mezz balance)
• Year 1 total yield: $30.8m = 8.8% on $350m total debt

Question: "Which coupon assumption would make you nervous?"
Answer: "If the senior coupon rises above 8.5% AND the mezz above 14% YTM, cash interest coverage falls below 2.0x — lenders will hesitate. At the current market range the structure holds, but every +100 bps of SOFR pushes coverage down by about 0.2x"

Second Lien fills a gap — it offers lenders an asset-backed investment with higher yield than senior but lower risk than mezzanine. Typical use case: a 1.0-1.5x EBITDA slot between senior at 4x and mezz at 0x.

Question: "When do you use 2L instead of mezz?"
Answer: "When cash flow is stable enough to carry the 2L cash coupon (no PIK). Mezz with PIK is more cash-flow-friendly but more expensive on a YTM basis"

HY bonds suit large-cap LBOs (>$500m deal size). In the middle market TLB dominates. In smaller middle markets the HY bond market is thin — US private placements / unrated private debt are the alternative.

Question: "Bond or loan?"
Answer: "For large deals (>$500m) a bond, for better market breadth. For the middle market a loan, because it is more flexible. Concretely: bonds are rare below large-cap; a TLB or a private placement is more common"

Mezzanine is "junior capital" with a senior-debt character — in modeling always treated as debt, not equity. PIK accrues year-over-year onto the balance.

Question: "Which mezz component is most sensitive in modeling?"
Answer: "The equity kicker — at an assumed exit multiple of 9x, a 2% warrant allocation moves sponsor equity by $6-8m. Whoever forgets the warrant overstates the equity value"

• Year-7 balance: $140.71m (= 100 + 40.71 PIK)
• Total return to lender over 7 years: $65.13m cash coupon + 100 principal repayment + 40.71 PIK repayment = $205.84m total return to lender (of which only $65.13m is true cash cost; PIK repayment is accreted principal)
• Effective YTM: ~13% (8% Cash + 5% PIK compounded)

Question: "What if the sponsor wants to repay the mezz before Year 7?"
Answer: "A soft-call premium — typically 102/101/100 in Year 3/4/5 against par. The soft-call premium makes it economically unattractive, so the sponsor rarely repays mezz voluntarily"

Private placements are common in the middle market as a TLB alternative — leaner documentation, longer investor relationships (buy-and-hold). In an LBO context they are used occasionally for strategics / family-owned targets, where sponsors tap the private-placement market.

Question: "Which non-public financing instrument do you know?"
Answer: "US private placements for the middle market, above all for family-owned targets and smaller banking relationships. Volume typically $50-200m, coupon similar to a HY bond, but bilaterally negotiated"

The platform company has an M&A pipeline of 3 bolt-ons at $30m each over 18 months. Instead of an equity refresh or a new TLB raise, the sponsor commits a $100m DDTL and draws it as each bolt-on closes.

The sponsor pays a premium for the optionality but can execute the M&A roll-up strategy without repeated lender approval.

Question: "When do you request a DDTL?"
Answer: "With a clearly defined M&A pipeline of 2–3 identified targets. In the middle market, typically for Buy-and-Build platforms with an aggressive add-on strategy"

The sponsor has an incentive to deleverage quickly — each 0.5x of EBITDA reduction cuts the coupon by 25bps. Over 5 years and $200m of debt = $2.5m cumulative savings.

Question: "How much is the ratchet worth in IRR?"
Answer: "Typically 100-150bps of IRR improvement over a 5-year hold, because the margin reduction frees up cash for sweep or distribution. The step-down is not symbolism but a material IRR lever"

"Pro Rata" gets its name because repayments and drawdowns are distributed equally across all pro-rata lenders. Institutional tranches have their own allocation mechanics.

Question: "Pro rata or institutional?"
Answer: "Pro rata when the banking relationship matters (common in the middle market). Institutional when the volume is larger and speed-to-close is critical (US style). A mix is usual: TLA pro rata + TLB institutional"

Holdco PIK is the most expensive form of debt — used only when all other sources are exhausted or the sponsor explicitly pulls out cash (recap).

Question: "When do you use Holdco PIK?"
Answer: "In a recap after Year 3-4 when leverage has fallen below 3x and the sponsor wants a 50%+ cash-out. Otherwise it distorts the capital structure uneconomically"

```
Sponsor (Equity)
↓
Holdco — issues Holdco PIK Notes
↓
TopCo / NewCo — no debt of its own
↓
OpCo — issues Senior + Mezzanine Debt
↓
Operating Subsidiary (asset-holding)
```

Question: "How would you model Holdco PIK recovery in a distressed analysis?"
Answer: "Structurally subordinated, typically 10–20% recovery, because all OpCo liabilities are served first. Check cross-guarantees pre-closing — they can flip the picture by hollowing out the structural separation"

TLB as bullet (standard, IRR optimization), TLA as amortizing (bank requirement). The sponsor optimizes the cash-flow profile and gives the lender reduction at the front end.

Question: "Bullet or amortizing?"
Answer: "TLB as bullet, TLA as amortizing — a mix is best practice. The sponsor optimizes the cash-flow profile for IRR, the lender gets an initial reduction. With pure bullet, the refi risk in Year 7 is substantial — in difficult market conditions the sponsor may be forced to refinance on poor terms"

If SOFR rises from 5.3% to 6.0%, the all-in coupon climbs to 10.25%, interest expense grows to $19.89m, and coverage falls to 2.51x. A +100 bps move in SOFR pushes coverage down by about 0.2x.

When does coverage hit the 2.0x trigger? At an all-in coupon of about 12.9% — which corresponds to SOFR around 8.65%, i.e. +335 bps versus today. Very unlikely in the current rate cycle, but standard as a stress test in modeling.

Sponsors often hedge 50–75% of the floating exposure with interest-rate swaps or caps. Cost is typically 50–150 bps p.a. — it reduces volatility but costs yield when rates fall.

Question: "At what SOFR rate would coverage fall to 2.0x?"
Answer: "At an all-in coupon of about 12.9% — so with SOFR around 8.65%. That's unlikely in the current cycle, but important as a stress test in modeling. A 50–75% interest-rate hedge is standard to dampen volatility during rate spikes"

The sponsor is protected against rate increases. Typically hedge 50-75% of the TLB volume, leaving the rest floating for optionality.

Question: "When do you hedge the TLB debt?"
Answer: "In high-rate periods a hedge pays off — if the forward curve is falling, staying floating is better. In the current setup (2024) the forward curve is flat, so hedge only 50% of the volume — keep the optionality"

Compounding: (1.05)^5 − 1 = 27.6%. After 5 years the sponsor repays $127.63m instead of $100m — that is meaningfully less equity value at exit.

Question: "Why would you choose PIK?"
Answer: "In years 1–2, when cash flow is still tight for servicing the senior. PIK is a cash-flow boost with a trade-off: higher total yield at exit. Standard in mezzanine, because the mezz coupon is high anyway (12–15%) and the PIK portion limits the cash burden in the early years"

Mezzanine $100m, 8% cash + 5% PIK + 1% equity kicker = 14% total yield.

• Low cash conversion (50-60%) = higher liquidity risk, more yield concentrated at exit
• High cash conversion (80%+) = the lender needs cash flow for investor distributions
• Mezzanine funds typically prefer 50-70% cash conversion — a balance between yield and liquidity

Question: "Why does the lender take PIK instead of 100% cash?"
Answer: "PIK is more cash-flow-friendly for the sponsor, which gives the mezz lender less distress exposure. As a compromise: mezz accepts 50-60% cash conversion in exchange for a premium on total yield"

TLB $200m face, issued at 99% (1% OID), 7-year term.

1. Cash interest = face × coupon (e.g. 200 × 7% = $14m cash)
2. Reported interest expense = cash interest + OID amortization (e.g. 14 + 0.286 = $14.29m)
3. Cash interest coverage uses only cash interest
4. Reported coverage uses total interest expense

Question: "Where do you see OID in the cash flow statement?"
Answer: "OID is non-cash — it shows up in the cash flow as an add-back (operating activities). In the model as a separate line, not in the cash coupon"

On $30m of undrawn RCF at a 175bps commitment fee: ~$525k per year in availability cost, even if never drawn. Over 7 years = ~$3.7m cumulative (at a constant $30m undrawn).

Question: "Is an RCF even worth it then?"
Answer: "In the middle market yes, because it cushions working-capital seasonality. The alternative — a higher cash reserve on the balance sheet — drags on IRR. A 175bps commitment fee is cheaper than the opportunity cost of holding liquidity"

A company with EBITDA $50m and gross interest of $22m.

1. The limit bites at aggressive leverage (>4x EBITDA almost always)
2. The interest carryforward accumulates over time and can be used later as EBITDA grows
3. Change-of-ownership rules (that restrict loss/interest carryforwards) can wipe out the carryforward at exit

Question: "What would your interest-carryforward effect be after 5 years?"
Answer: "At a steady $7m non-deductible p.a. you build a $35m interest carryforward, which can be used again as you de-lever and EBITDA grows in years 4-5. In effect the tax shield is only deferred, not lost — as long as the change-of-ownership rules don't bite"

• Cash on the balance sheet earns less than the debt costs → the sponsor should use excess cash to pay down debt
• Interest income reduces net interest expense in the model — a smaller effect
• With a minimum-cash floor (e.g. $10m) income modeling is worthwhile, otherwise marginal

Question: "How large is interest income in your model?"
Answer: "Marginal — typically $0.5-1.5m p.a. with a minimum-cash floor of $10-30m. It reduces net interest but isn't a material driver"

```
PE Fund (Luxembourg SCSp / Cayman / Delaware LP)
↓
HoldCo (Luxembourg)
↓
TopCo / BidCo (acquisition vehicle, often in the target's country)
↓
OpCo (local operating target)
```

Comparison: local HoldCo vs LuxCo:

Since BEPS Action 6 (anti-treaty-shopping, implemented through the principal purpose test in the Multilateral Instrument) and the CJEU's 2019 'Danish cases' on beneficial ownership, the LuxCo needs real substance — resident directors, decision-making in Luxembourg, an office and ideally staff. Letterbox setups risk losing treaty and Directive benefits.

Question: "Why are there so many Lux structures?"
Answer: "Participation exemption on dividends and exit gains, withholding-free upstreaming via the Parent-Subsidiary Directive and PEC or alphabet-share instruments, and a treaty network LPs trust. It is not an interest-deduction play any more — Luxembourg applies the ATAD cap too. Since BEPS and the Danish cases, substance is mandatory, not lip service."

European Industrial Co is conservatively structured. If the senior tranche were raised to $200m (5.0x EBITDA), the coverage ratios would move into a more critical zone and maintenance covenants would be set tighter.

Question: "Which ratio would you watch first?"
Answer: "Cash interest coverage. With floating-rate debt it erodes quickly as coupons rise. It is also very sensitive to EBITDA drops — a 10–20% EBITDA decline is often enough to breach maintenance covenants"

At 22% headroom, EBITDA can fall ~18% before the covenant is breached. At 10% headroom, the tolerance is only 9% — very tight, every quarterly weakness is critical.

Question: "How high should initial headroom be?"
Answer: "Typically 25-35% at closing. The sponsor negotiates for more (40%+), the lender wants less (15-20%). Middle-market standard: 30%"

1. EBITDA adjustment: the equity injection is counted virtually as additional EBITDA (e.g. 50 / 1 = $50m EBITDA boost). Senior Debt / EBITDA is recalculated
2. Debt reduction: cure equity is used for repayment — a direct effect on the numerator

The equity cure is the sponsor's shield against cyclical downturns. But: cure frequency is limited (typically max 2 in a row, max 4 total) — for structural problems that is not enough.

Question: "Why does a lender accept an equity cure?"
Answer: "Win-win: the lender gets a skin-in-the-game signal from the sponsor (commitment), the sponsor gets a cushion against short-term weakness. But cure-equity volume is usually capped at 25-35% of the original EBITDA shortfall"

Cov-Lite was rare in 2008–2015. Since 2015 it has taken hold in over 75% of US TLB deals. In Europe and the middle market the share is still under 50%, but the trend is rising.

Question: "Why do lenders accept Cov-Lite?"
Answer: "A liquidity glut in the CLO markets and lender competition push structures to be sponsor-friendly. The flip side: loss given default on Cov-Lite is typically 15–25% higher than on maintenance loans, because distress becomes visible later"

Question: "Which add-back is the most controversial?"
Answer: "Synergies. Look-forward, burden of proof on the sponsor. With a DD report and a clear realization plan, 60–80% is acceptable. Without a plan, more like 30–50%. In the middle market it is often the decisive negotiation point"

The sponsor wants maximum flexibility, the lender wants control. Negotiation room:

• Sector restriction: usually accepted (specialization)
• Aggregate limit: typically 25-35% of EBITDA over the term
• Pro-forma leverage test: typically 5.5-6.0x for add-ons

> "Permitted acquisitions are allowed provided that (i) pro-forma senior leverage < 5.75x, (ii) pro-forma total leverage < 6.5x, (iii) the aggregate purchase price of all acquisitions does not exceed 30% of EBITDA at closing, (iv) the acquisition is in the same or a related sector."

Question: "Would you combine a Buy-and-Build platform with Cov-Lite?"
Answer: "A classic combination. Cov-Lite + generous permitted acquisitions = sponsor-friendly. Lenders often accept it when the sponsor has a clear M&A pipeline and track record"

`Average Life = 395 / 100 = 3.95 years`

• Lower average life = lower risk = lower coupon
• Higher average life (e.g. 7-year bullet) = higher coupon premium (~50-100bps)
• In the pricing model, important for the yield-to-maturity calculation

Question: "What is the average life of your TLB?"
Answer: "The TLB is a 7-year bullet, so average life ≈ 7. That explains the 75-100bps premium over a TLA with 3-4 years average life. Relevant in a pricing comparison"

Question: "How do you define net debt in the pitch?"
Answer: "Broader in pricing — add pension, IFRS 16 lease, and Vendor Loan. Narrower in the covenant test — typically Senior + Mezzanine. Clarify both definitions explicitly, because sector-specific conventions vary"

• EBITDA falls from $40m to $32m
• Senior leverage rises from 4.0x to 5.0x
• Maintenance cap: 4.75x → breach

The sponsor provides an equity cure of $8m. EBITDA is lifted virtually to $40m, leverage back to 4.0x. The cure limit is usually capped at 2 cures per 12-month period.

• Lender position on breach: leverage for a higher margin or new terms.
• Sponsor position: inject more equity or accept restructuring.
• Reputation: repeated breaches on a PE track record hurt at the next fundraise.

Question: "As a sponsor, what would you do in a covenant breach?"
Answer: "Talk to the lender proactively and immediately, before the cure period lapses. Equity cure as the short-term fix, a restructuring plan as the medium-term one. Lenders value transparency more than attempts to disguise the breach"

• EBITDA / Interest at 3.1x looks comfortable
• After capex only 2.5x — tight when capex-intensive
• In machinery (15-20% capex/sales) often a critical test

Question: "Which coverage test is relevant?"
Answer: "(EBITDA − Capex) / Interest, because it shows the real cash-flow capacity for interest service. In capex-intensive sectors at least 1.5x as a floor, otherwise distress risk"

Maturity should be 1–2 years longer than the planned hold period, to keep optionality for a hold extension.

If the sponsor holds longer than planned (e.g. Year 6 instead of 5), the TLB maturity draws near. Refinancing risk becomes pricing-relevant — in a difficult market banks can demand higher spread premiums.

Question: "How do you structure maturities?"
Answer: "Senior 7-year bullet, Mezzanine 8–9 years — the Mezzanine always longer than the senior, otherwise inside-maturity risk. With a 5–7 year hold that gives enough refi optionality without market conditions at the exit date holding the sale to ransom"

The cushion test is absolute protection for the lender — independent of debt modifications. It is often used when:

1. the sponsor de-levers aggressively (senior debt falls faster than the EBITDA decline)
2. the lender wants to guarantee minimum coupon coverage
3. the sector has volatile EBITDA (consumer goods, construction, automotive)

Question: "When is a cushion test more useful than a leverage ratio?"
Answer: "In volatile sectors — a leverage ratio can be 'cured' by aggressive de-leveraging, while an EBITDA floor protects directly. In the middle market it is fairly unusual, but in cyclical sectors it is often combined"

An LSA makes the senior lender stronger and the junior lender weaker. The junior accepts this for a coupon premium — second lien is typically 275 bps over first lien.

Question: "What would the junior lender's position be in distress?"
Answer: "Heavily constrained by the LSA — typically a 6-month standstill, after which acceleration is possible only with senior consent. Standard in the middle market. It protects the senior lender; the junior coupon premium compensates for the risk"

Question: "Why does a lender accept a springing covenant?"
Answer: "It protects the lender when the line is actually used. With an undrawn RCF there is less risk — the sponsor benefits from a compliance-free period, and the lender only tests on activation"

The modeling forecast shows senior leverage at 4.5x at closing, falling to 3.5x over 5 years. The sponsor negotiates an initial 5.75x, stepping down to 4.75x in Year 3 and 4.25x in Year 5. Cushion: 5.75 − 4.5 = 1.25x = 28% — within the market range.

Question: "Which step-down is negotiable?"
Answer: "The sponsor wants 0.1–0.15x p.a., the lender wants 0.25x p.a. Compromise: 0.15–0.2x with a 25–35% cushion at closing. The step-down should stay behind the modeling forecast, otherwise the safety margin is gone"

An existing TLB of $200m at SOFR + 425 bps. The sponsor plans a $100m add-on.

An MFN sunset (12–24 months) is standard in the middle market — after that the sponsor has more room for add-ons under a Buy-and-Build.

Question: "Why does a lender accept an MFN sunset?"
Answer: "Protection from pricing erosion matters most in the early period — after that the lender has refi options anyway. The sponsor wants flexibility for an M&A roll-up. A typical compromise: 18 months of MFN, then a sunset"

A 33% EBITDA lift is within the market range. Above 40% the lender gets skeptical — the quality of earnings (QoE) is scrutinized intensively, and the banker typically cuts 30–50% of synergies.

Question: "What is a red flag in the add-back stack?"
Answer: "Synergies above 20%, owner adjustment above 15%, or aggregate above 50% — all triggers for deeper DD. The European middle market is more conservative than the US market"

• Negotiate the Mezzanine maturity at least 1–2 years longer than the senior.
• A "maturity cap" clause in the intercreditor agreement: the Mezzanine may not mature while the senior is outstanding.

Question: "What would your plan be for an inside maturity?"
Answer: "Avoid it at all costs — negotiate the Mezzanine maturity at least 1–2 years longer than the senior. Pay close attention through refi cycles, otherwise an inside maturity creeps in and creates restructuring risk"

• The sponsor pays a nominal 7.75% coupon, effectively 8.1–8.3% YTM.
• Over time the coupon dominates and the fee amortization becomes marginal.
• On early repayment, a make-whole or soft-call premium applies (typically 101 for 6 months, then par).

Question: "What is your true cost of capital?"
Answer: "All-in YTM, not just the coupon. SOFR 3.5% + 425 bps + fee amortization = about 8.2%. Standard in the middle market; depending on sector and sponsor track record it varies by ±50 bps"

1. Assess EBITDA stability: a volatility score by sector, cyclicality, customer concentration.
2. Capex profile: higher → lower leverage capacity.
3. Stress test: at −20% EBITDA is coverage still above 1.5x?
4. Sector benchmark: comparables from the middle market.

Aggressive 5.5x senior + 1.5x sub = 7.0x total; Standard 5.0x + 1.0x = 6.0x; Conservative 4.5x + 0.5x = 5.0x.

Question: "What senior leverage would you propose?"
Answer: "Sector-specific. For middle-market machinery 4.5–5.0x as the base case, 5.5x in the aggressive case with clearly demonstrated synergies. Above 5.5x the lender turns conservative — coverage above 2.0x is then no longer guaranteed"

• "Leverage at closing" for the pricing discussion with the lender.
• "Peak leverage" (Year 2 here) for covenant design: the cushion must fit it.
• "Through-the-cycle" for the IC memo: the long-term risk view.

For cyclical targets the closing leverage looks moderate, but the mid-period can trigger a covenant breach.

Question: "In which year is leverage highest?"
Answer: "Year 1–2, because EBITDA is not yet fully synergized AND senior debt is still almost unchanged. The cushion on the maintenance covenant is tightest in this phase — typically 20–25%"

EBITDA growth and de-leveraging each contribute roughly half — a healthy structure. When a senior asks where the returns come from, this disaggregation is the answer.

Question: "How much of the return is EBITDA growth versus de-leveraging?"
Answer: "EBITDA grew 50 → 70 = +40%, which added +$160m of EV. De-leveraging took Senior Debt from $250 down to $80 — so +$170m of equity build. The two effects are roughly equal. On a pure multiple-expansion story the investment thesis would be questionable — here most of it comes from the sponsor's own hand"

At 7 years the sponsor needs 3.58x — substantially harder than the 2.49x for 5 years. Compounding takes its toll.

The sponsor optimizes exit timing between "enough EBITDA growth realized" and "compounding advantage not yet lost to time". In a volatile market the hold can be extended to wait out multiple compression — continuation vehicles are the typical tool for that.

Question: "Why is 5 years the standard?"
Answer: "It balances IRR optimization and value creation. Under 4 years there isn't enough operational improvement to show; over 7 years time decay eats the IRR. 5 years is the sweet spot — the market has settled around that median"

The CV market grew strongly from 2020 to 2024 — over $100B of volume per year globally. The middle-market segment is still small, but rising.

Question: "Why has the CV trend risen?"
Answer: "Three drivers: (1) fund-lifecycle pressure on star assets, (2) Buy-and-Build platforms need longer hold periods, (3) LP demand for liquidity options. CVs are increasingly becoming a standard option in the middle market"

Question: "Which multiple driver is the most sensitive?"
Answer: "Sector sentiment and the EBITDA growth rate. In machinery, a 10%+ growth CAGR earns a premium multiple, otherwise a discount. In the middle market it also matters whether the target is international or domestic-only — the former widens the buyer pool to Asian and US strategics"

At exit after 5 years: EBITDA $50m (organic + synergies), multiple 11x → Exit EV $550m.

Often used in a pitch: "We buy add-ons at 6–7x and integrate them onto the platform at 9x — multiple arbitrage of 2–3x per add-on." Seniors test this with "What if synergies aren't fully realized?" Answer: "Sensitivity test at 50% synergy realization — multiple arbitrage falls to 1.5–2x. Always show the worst case in the IC memo."

```
Month 0–3: Bank mandates for the dual track
Month 3–6: Parallel preparation (IPO prospectus + M&A process)
Month 6–9: First-round bids (strategic) + IPO roadshow investors
Month 9–12: Sponsor decides which route (pricing comparison)
Month 12–15: Execution & closing
```

Question: "When does a dual track make sense?"
Answer: "For large caps above $500m EV where an IPO is realistic. In the middle market it is typically single track only — the complexity cost exceeds the pricing leverage. Essentially never below $300m EV"

On net equity to the sponsor: Strategic Sale > Sponsor-to-Sponsor > IPO.

• Partial exit: the sponsor can sell 30–50% and keep the rest (lock-up typically 6 months).
• Liquidity optionality for future tranches.
• Public currency for M&A financing.

Question: "When do you choose an IPO despite the discount?"
Answer: "When the sponsor's brand needs public visibility, an M&A pipeline with equity currency is possible, or the strategic bidder pool is too small. On a pure-IRR view the strategic sale is usually better"

Question: "Would you accept an earn-out in the pitch?"
Answer: "Yes, if clearly defined — a specific EBITDA definition, no 'reasonable adjustments' language. An earn-out reduces closing cash and shares performance risk with the seller. Win-win on family deals"

When does stock-for-stock make sense?

Tax deferral has time value — the deferred tax stays invested. But: share-price risk until disposal, and the lock-up period reduces liquidity optionality.

Question: "Would you accept a stock sale?"
Answer: "Rarely as a sponsor — we need cash to return to LPs, and stock adds share-price and lock-up risk. It works best in the US through a §368 reorganization, or with a large, liquid listed buyer whose shares we could distribute in kind. Otherwise a cash sale is preferred for certainty."

A 50%+ erosion between EV and after-tax cash. The bridge is mandatory in the IC memo.

Question: "Where is the biggest erosion in the bridge?"
Answer: "In the middle market: PIK accretion on sub-debt (10–15% of the EV reduction) and tax (15–20% of the equity value depending on structuring). On middle-market targets, often also a pension liability above 5% of EV"